Updated risk factor values and the ability of the multivariable risk score to predict coronary heart disease

American Journal of Epidemiology

Volumn 160, Issue 7, 2004, Pages 707-716

  Karp, Igor ^a,b   Abrahamowicz, Michal ^a,b   Bartlett, Gillian ^a,c   Pilote, Louise ^a,b  

^a MCGILL UNIVERSITY   (Canada)

^b MONTREAL GENERAL HOSPITAL   (Canada)

^c ROYAL VICTORIA HOSPITAL   (Canada)

Author keywords

Cohort studies; Coronary disease; Logistic models; Proportional hazards models; Risk assessment; Risk factors; Validation studies publication type

Indexed keywords

CHOLESTEROL;

CARDIOVASCULAR DISEASE; COHORT ANALYSIS; MEDICAL GEOGRAPHY; MODELING; RISK FACTOR;

ADULT; ARTICLE; BLOOD PRESSURE; BODY MASS; CHOLESTEROL BLOOD LEVEL; COHORT ANALYSIS; CORONARY RISK; FEMALE; FOLLOW UP; GLUCOSE INTOLERANCE; HUMAN; ISCHEMIC HEART DISEASE; MAJOR CLINICAL STUDY; MALE; PROGNOSIS; RISK ASSESSMENT; SMOKING; STATISTICAL ANALYSIS;

ADULT; COHORT STUDIES; CORONARY DISEASE; FEMALE; FOLLOW-UP STUDIES; HUMANS; LOGISTIC MODELS; MALE; MIDDLE AGED; MULTIVARIATE ANALYSIS; PROGNOSIS; PROPORTIONAL HAZARDS MODELS; RISK ASSESSMENT; RISK FACTORS;

EID: 4644324821     PISSN: 00029262     EISSN: None     Source Type: Journal    
DOI: 10.1093/aje/kwh258     Document Type: Article

References (54)

1. Anderson KM, Odell PM, Wilson PWF, et al. Cardiovascular disease risk profiles. Am Heart J 1991;121:293-8.
2. Assmann G, Cullen P, Schulte H. Simple scoring scheme for calculating the risk of acute coronary events based on the 10-year follow-up of the Prospective Cardiovascular Munster (PROCAM) Study. Circulation 2002;105:310-15.
3. Wilson PWF, D'Agostino RB, Levy D, et al. Prediction of coronary heart disease using risk factor categories. Circulation 1998;97:1837-47.
4. Ramsay LE, Haq IU, Jackson PR, et al. Targeting lipid-lowering drug therapy for primary prevention of coronary disease: an updated Sheffield table. Lancet 1996;348:387-8.
5. Tunstall-Pedoe H. The Dundee coronary risk-disk for management of change in risk factors. BMJ 1991;303:744-7.
6. Shaper AG, Pocock SJ, Phillips AN, et al. Identifying men at high risk of heart attacks: strategy for use in general practice. BMJ (Clin Res Ed) 1986;293:474-9.
7. Prevention of coronary heart disease in clinical practice. Recommendations of the Second Joint Task Force of European and Other Societies on Coronary Prevention. Eur Heart J 1998;19:1434-503.
8. Miettinen OS. Stratification by a multivariate confounder score. Am J Epidemiol 1976;104:609-20.
9. Roman MJ, Shanker BA, Davis A, et al. Prevalence and correlates of accelerated atherosclerosis in systemic lupus erythematosus. N Engl J Med 2003;349:2399-406.
10. Esdaile JM, Abrahamowicz M, Grodzicky T, et al. Traditional Framingham risk factors fail to fully account for accelerated atherosclerosis in systemic lupus erythematosus. Arthritis Rheum 2001;44:2331-7.
11. Peduzzi P, Concato J, Kemper E, et al. A simulation study of the number of events per variable in logistic regression analysis. J Clin Epidemiol 1996;49:1373-9.
12. Prentice RL. Surrogate endpoints in clinical trials. Stat Med 1989;8:431-40.
13. Psaty BM, Weiss NS, Furberg CD, et al. Surrogate end points, health outcomes, and the drug approval process for the treatment of risk factors for cardiovascular disease. JAMA 1999;282:786-90.
14. Benfante R, Hwang LJ, Masaki K, et al. To what extent do cardiovascular risk factor values measured in elderly men represent their midlife values measured 25 years earlier? A preliminary report and commentary from the Honolulu Heart Program. Am J Epidemiol 1994;140:206-16.
15. Zavaroni I, Ardigo D, Massironi P, et al. Do coronary heart disease risk factors change over time? Metabolism 2002;51:1022-6.
16. Clarke R, Shipley M, Lewington S, et al. Underestimation of risk associations due to regression dilution in long-term follow-up of prospective studies. Am J Epidemiol 1999;150:341-53.
17. D'Agostino RB, Russell MW, Huse DM, et al. Primary and subsequent coronary risk appraisal: new results from the Framingham Study. Am Heart J 2000;139:272-81.
18. Wu M, Ware JH. On the use of repeated measurements in regression analysis with dichotomous responses. Biometrics 1979;35:513-21.
19. Kawachi I, Colditz GA, Stampfer MJ, et al. Smoking cessation and time course of decreased risks of coronary heart disease in middle-aged women. Arch Intern Med 1994;154:169-75.
20. Law MR, Wald NJ, Thompson SG. By how much and how quickly does reduction in serum cholesterol concentration lower risk of ischaemic heart disease? BMJ 1994;308:367-72.
21. Downs JR, Clearfield M, Weiss S, et al. Primary prevention of acute coronary events with lovastatin in men and women with average cholesterol levels: results of AFCAPS/TexCAPS. Air Force/Texas Coronary Atherosclerosis Prevention Study. JAMA 1998;279:1615-22.
22. Pekkanen J, Tervahauta M, Nissinen A, et al. Does the predictive value of baseline coronary risk factors change over a 30-year follow-up? Cardiology 1993;82:181-90.
23. Vasan RS, Massaro JM, Wilson PWF, et al. Antecedent blood pressure and risk of cardiovascular disease. The Framingham Heart Study. Circulation 2002;105:48-53.
24. Wilson PWF, Hoeg JM, D'Agostino RB, et al. Cumulative effects of high cholesterol levels, high blood pressure, and cigarette smoking on carotid stenosis. N Engl J Med 1997;337:516-22.
25. Nieto FJ, Diez-Roux A, Szklo M, et al. Short- and long-term prediction of clinical and subclinical atherosclerosis by traditional risk factors. J Clin Epidemiol 1999;52:559-67.
26. Hakim AA, Curb JD, Burchfiel CM, et al. Screening for coronary heart disease in elderly men based on current and past cholesterol levels. J Clin Epidemiol 1999;52:1257-65.
27. Wannamethee SG, Shaper AG, Whincup PH, et al. Role of risk factors for major coronary heart disease events with increasing length of follow up. Heart 1999;81:374-9.
28. Menotti A, Lanti M. Coronary risk factors predicting early and late coronary deaths. Heart 2003;89:19-24.
29. Cupples LA, D'Agostino RB, Anderson K, et al. Comparison of baseline and repeated measure covariate techniques in the Framingham Heart Study. Stat Med 1988;7:205-18.
30. D'Agostino RB, Lee ML, Belanger AJ, et al. Relation of pooled logistic regression to time-dependent Cox regression analysis: the Framingham Heart Study. Stat Med 1990;9:1501-15.
31. Cox DR. Regression models and life tables (with discussion). J R Stat Soc (B) 1972;34:187-220.
32. Zeger SL, Liang KY. Longitudinal data analysis for discrete and continuous outcomes. Biometrics 1986;42:121-30.
33. Liang KY, Zeger SL. Longitudinal data analysis using generalized linear models. Biometrika 1986;73:13-22.
34. Kannel W, Wolf P, Garrison R, eds. The Framingham Study: an epidemiological investigation of cardiovascular disease. Washington, DC: US Department of Commerce, 1988.
35. Abbott RD, Curb JD, Rodriguez BL, et al. Age-related changes in risk factor effects on the incidence of coronary heart disease. Ann Epidemiol 2002;12:173-81.
36. Barrett-Connor E. Sex differences in coronary heart disease. Why are women so superior? The 1995 Ancel Keys Lecture. Circulation 1997;95:252-64.
37. Franklin SS, Larson MG, Khan SA, et al. Does the relation of blood pressure to coronary heart disease risk change with aging? The Framingham Heart Study. Circulation 2001;103:1245-9.
38. Kannel WB, Wilson PWF. Risk factors that attenuate the female coronary disease advantage. Arch Intern Med 1995;155:57-61.
39. Wilson PWF, Castelli WP, Kannel WB. Coronary risk prediction in adults (the Framingham Heart Study). Am J Cardiol 1987;59:91G-4G.
40. Central Patient Registry and Coordinating Centre for the Lipid Research Clinics. Reference manual for the Lipid Research Clinics Prevalence Study. Vols 1 and 2. Chapel Hill, NC: University of North Carolina, 1974.
41. Abrahamowicz M, du Berger R, Grover S. Flexible modeling of the effects of serum cholesterol on coronary heart disease mortality. Am J Epidemiol 1997;145:714-29.
42. Jennrich RI, Schluchter MD. Unbalanced repeated-measures models with structured covariance matrices. Biometrics 1986;42:805-20.
43. Zeger SL, Liang KY. Models for longitudinal data: a generalized estimating equations approach. Biometrics 1988;44:1049-60.
44. Nagelkerke NJD. A note on a general definition of the coefficient of determination. Biometrika 1991;78:691-2.
45. Harrell FE, Califf RM, Pryor DB, et al. Evaluating the yield of medical tests. JAMA 1982;247:2543-6.
46. Hanley JA, McNeil BJ. The meaning and use of the area under a receiver operating characteristic (ROC) curve. Radiology 1982;143:29-36.
47. Efron B, Tibshirani RJ. An introduction to the bootstrap. New York, NY: Chapman & Hall, 1993.
48. Harrell FE, Lee KL, Mark DB. Multivariable prognostic models: issues in developing models, evaluating assumptions and adequacy, and measuring and reducing errors. Stat Med 1996;15:361-87.
49. de Vries CL, Feskens EJM, Coulander CL, et al. Repeated measurements of serum cholesterol and blood pressure in relation to long-term incidence of myocardial infarction. Cardiology 1993;82:89-99.
50. Tornberg SA, Jacobson KFS, Eklund GA. Stability and validity of a single serum cholesterol measurement in a prospective cohort study. Int J Epidemiol 1988;17:797-803.
51. Thompson SG, Pocock SJ. The variability of serum cholesterol measurements: implications for screening and monitoring. J Clin Epidemiol 1990;43:783-9.
52. Liao Y, McGee DL, Cooper RS, et al. How generalizable are coronary risk prediction models? Comparison of Framingham and two national cohorts. Am Heart J 1999;137:837-45.
53. Emond MJ, Zareba W. Prognostic value of cholesterol in women of different ages. J Womens Health 1997;6:295-307.
54. Niccoli G, Iacoviello L, Cianflone D, et al. Coronary risk factors: new perspectives. Int J Epidemiol 2001;30(suppl 1):S41-7.